1.85
Bullfrog Ai Holdings Inc (BFRG) 最新ニュース
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Up 18.7% in March - Defense World
Join Bullfrog AI's Exclusive Live Investor Webinar and Q&A Session on April 23 - The Manila Times
BullFrog AI CEO to Showcase Johns Hopkins-Backed Drug Development Platform That's Revolutionizing Biopharma - Stock Titan
Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23 - Yahoo Finance
15,000 Shares in Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Purchased by Raymond James Financial Inc. - Defense World
Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Corsicana Daily Sun
Bullfrog AI Holdings Inc (BFRG) Shares Rise Despite Market Challenges - News Heater
Bullfrog AI CEO Vininder Singh sells $7,686 in common stock - Investing.com Australia
Bullfrog AI CEO Vininder Singh sells $7,686 in common stock By Investing.com - Investing.com India
Bullfrog AI CEO Vininder Singh sells $66,407 in stock By Investing.com - Investing.com Canada
Bullfrog AI CEO Vininder Singh sells $66,407 in stock - Investing.com Australia
BFRG stock touches 52-week low at $1.4 amid market challenges - Investing.com Australia
BFRG stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa
WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - Quantisnow
AI Influence on Medical Diagnostics Generating Billion - GlobeNewswire
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs - Financial Content
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Down 28.2% in February - Defense World
Bullfrog AI Holdings Inc. (BFRG) reports earnings - Quartz
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Sees Significant Increase in Short Interest - Defense World
BullFrog AI partners with Eleison to enhance Phase III trial - MSN
BullFrog AI Partners With Eleison Pharmaceuticals To Optimize Phase 3 Pancreatic Cancer Trial - Nasdaq
BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial - The Manila Times
Can AI Technology Improve Pancreatic Cancer Trial Success? BullFrog's New Partnership Targets Deadly Disease - StockTitan
Bullfrog AI Holdings, Inc. (BFRG) to Discuss Breakthrough Psychiatric Research in Fireside Chat on March 5 - Insider Monkey
The AI Arms Race: How DeepSeek and Grok Are Shaking Up Wall Street - Zaman
The AI Race Intensifies: From Revolutionary Chatbots to Groundbreaking Medical Insights - Smartphone Magazine
10 Buzzing AI Stocks Dominating Headlines - Insider Monkey
Taking a look at what insiders are doing to gauge the Bullfrog AI Holdings Inc (BFRG)’s direction - Knox Daily
Can BullFrog AI Continue to Leap Higher? - Zacks Investment Research
Taking on analysts’ expectations and winning: Bullfrog AI Holdings Inc (BFRG) - SETE News
Understanding BFRG’s financial ratios: A beginner’s guide - US Post News
Bullfrog AI Holdings Inc (BFRG) Stock: From Low to High in 52 Weeks - The InvestChronicle
Bullfrog AI Holdings Inc (BFRG) Stock: Analyzing the Market Value - The News Heater
Bullfrog AI Holdings Insiders Benefitted From Selling Stock At US$2.41 - Simply Wall St
Press Release Distribution & PR Platform - ACCESS Newswire
BullFrog AI to Present at Benzinga All Access Event on Friday, February 17 - ACCESS Newswire
BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer - ACCESS Newswire
BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic - ACCESS Newswire
BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - The Manila Times
BullFrog AI to Showcase Revolutionary AI-Powered Drug Development Platform at JPM Healthcare Conference - StockTitan
Bullfrog AI Sends Letter to Stockholders, Highlighting Achievements and Strategic Direction - Defense World
Bullfrog AI CEO: 2025 focus will remain on AI-driven solution commercialization - Yahoo Finance
BullFrog AI Issues Letter to Stockholders - EIN News
BullFrog AI Expands AI Platform, Secures Johns Hopkins Tech License & Advances Drug Pipeline - StockTitan
Certain Common Stock of Bullfrog AI Holdings, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2024. - Marketscreener.com
BullFrog AI Holdings Appoints Josh Blacher as CFO - citybiz
BullFrog AI Names Josh Blacher as New CFO - TipRanks
大文字化:
|
ボリューム (24 時間):